04:16 AM EST, 11/11/2025 (MT Newswires) -- Stereotaxis ( STXS ) said Monday it has received US Food and Drug Administration clearance for its GenesisX robotic magnetic navigation system for endovascular surgery.
The company said it has initiated a limited launch of GenesisX in the US and Europe.